The Genotyping Assay Market refers to the industry segment that develops and offers assays, kits, platforms, and services for determining genetic variations among individuals, including single ...

Expression Analysis, Inc. has entered into an agreement with GlaxoSmithKline to provide microarray based genotyping services. "We are pleased to support GSK microarray-based genotyping requirements," ...

To map most of the genetic variation in the human genome, scientists need to look at several hundred thousand single nucleotide polymorphisms (SNPs) per individual. Most genotyping assays employ ...

Global Genotyping Assay Market is valued at USD 14.36 Billion in 2022 and is projected to attain a value of USD 60.52 Billion by 2030 at a CAGR of 19.70% during the forecast period, 2022–2028. The ...

DNA microarray is one of the most useful tools in the Viral Genome Screening such as Human Papilomavirus(HPV). Using type specific probes of about 30 mer oligonucleotide DNA sequences based upon the ...

has landed a contract with GlaxoSmithKline to provide the pharmaceutical giant with microarray-based genotyping services. Microarray technology enables researchers to genetic information such as gene ...

Customers can now use the end-to-end solution to translate research to the clinic to improve disease outcomes in the future. (PRNewsfoto/Allelica, Inc.) The genetic research and medical communities ...

Recently published data generated by researchers at The University of Queensland and Vaxxas shows effective delivery of a nucleic acid-based COVID-19 vaccine in a preclinical animal study utilizing ...